Innovative Trauma Care (ITC), an Edmonton, Canada and San Antonio, Texas-based early-stage medical device firm focused on developing point of injury solutions for trauma, first responder and military medicine applications, has closed its $3.64m Series A funding round.
Backers were not disclosed.
The company intends to use the capital to prepare the commercialization efforts for its first product, the ITClampTM Hemorrhage Control System.
Incorporated in 2010, Innovative Trauma Care received a license for sale from Health Canada, the Federal department that reviews medical devices to assess their safety and effectiveness, in September 2012. It now expects the CE Mark from the European Union in late 2012 and US clearance from the FDA in 2013.
The ITClamp was designed to address massive hemorrhage – a leading cause of death in traumatic injury – by controlling critical bleeding in as little as five seconds. The clamping device works by sealing the skin closed to create a temporary pool of blood under pressure, which forms a stable clot until the wound can be surgically repaired.